Explained: FDA removes warning label from hormone treatments for menopause; what happens now (risk factors and safe practice tips)

The FDA is removing the “black box” warning from many hormone therapies for menopause symptoms, citing new research showing lower risks for women under 60 or within 10 years of menopause. This shift encourages individualized treatment decisions, balancing benefits against potential risks based on a woman’s health profile.